25 Acceptance of the IBSC approval for seeking permission to manufacture test items for examination, test and analysis through form CT-10 as per the recommendation of the 314th RCGM meeting, dated 09.
In force — no superseding record on file.
File No.:VAC-11011(11)/10/2025-eoffice [E CompoNo.:27052]
Ministry of Health and Family Welfare
Directorate General of Health Services
Central Drugs Standard Control Organization (HQ)
(Biological Division)
FDA Bhawan, Kotla Road
New Delhi -110002
Date: 0 3 SEP 2025
Circular
Sub: Acceptance of the IBSC approval for seeking permission to manufacture
test items for examination, test and analysis through form CT 10 as per the
recommendation of the 314th RCGM meeting, dated 09.07.2025.
This is with reference to the letter no. PID-15011 (11)/3112021-PPB-DBT, dated
21.07.2015 from the Member Secretary, RCGM, Department of Biotechnology,
Ministry of Science and Technology, Government of India (copy enclosed) on the
subject matter for your information and further necessary action.
(Dr. Raj
v
.
Drugs Controller:
To:
- All Biopharmaceutical manufacturers (Vaccine/r-DNA/others).
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
Acceptance of the IBSC approval for seeking permission to manufacture
No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 24418 --apply.